Dermatan sulfate and bone marrow mononuclear cells used as a new therapeutic strategy after arterial injury in mice

References

• Zhang QH, She MP. Biological behaviour and role of endothelial progenitor cells in vascular diseases. Chin Med J (Engl). 2007;120:2297–303.
   PubMedGoogle Scholar
• Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, . Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964–7.
   PubMed Web of Science ®Google Scholar
• Ribatti D. The discovery of endothelial progenitor cells. An historical review. Leuk Res. 2007;31:439–44.
   PubMed Web of Science ®Google Scholar
• Zampetaki A, Kirton JP, Xu Q. Vascular repair by endothelial progenitor cells. Cardiovasc Res. 2008;78:413–21.
   PubMed Web of Science ®Google Scholar
• Werner N, Junk S, Laufs U, Link A, Walenta K, Bohm M, . Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res. 2003;93:e17–24.
   PubMed Web of Science ®Google Scholar
• Tovar AM, de Mattos DA, Stelling MP, Sarcinelli-Luz BS, Nazareth RA, Mourao PA. Dermatan sulfate is the predominant antithrombotic glycosaminoglycan in vessel walls: implications for a possible physiological function of heparin cofactor II. Biochim Biophys Acta. 2005;1740:45–53.
   PubMedGoogle Scholar
• Tollefsen DM, Pestka CA, Monafo WJ. Activation of heparin cofactor II by dermatan sulfate. J Biol Chem. 1983;258: 6713–6.
   PubMed Web of Science ®Google Scholar
• Vicente CP, He L, Tollefsen DM. Accelerated atherogenesis and neointima formation in heparin cofactor II deficient mice. Blood. 2007;110:4261–7.
   PubMed Web of Science ®Google Scholar
• Gozzo AJ, Nunes VA, Carmona AK, Nader HB, von Dietrich CP, Silveira VL, . Glycosaminoglycans affect the action of human plasma kallikrein on kininogen hydrolysis and inflammation. Int Immunopharmacol. 2002;2:1861–5.
   PubMedGoogle Scholar
• Belmiro CL, Castelo-Branco MT, Melim LM, Schanaider A, Elia C, Madi K, . Unfractionated heparin and new heparin analogues from ascidians (chordate-tunicate) ameliorate colitis in rats. J Biol Chem. 2009;284:11267–78.
   PubMed Web of Science ®Google Scholar
• Monzavi-Karbassi B, Stanley JS, Hennings L, Jousheghany F, Artaud C, Shaaf S, . Chondroitin sulfate glycosaminoglycans as major P-selectin ligands on metastatic breast cancer cell lines. Int J Cancer. 2007;120:1179–91.
   PubMedGoogle Scholar
• He L, Vicente CP, Westrick RJ, Eitzman DT, Tollefsen DM. Heparin cofactor II inhibits arterial thrombosis after endothelial injury. J Clin Invest. 2002;109:213–9.
   PubMed Web of Science ®Google Scholar
• Leidenfrost JE, Khan MF, Boc KP, Villa BR, Collins ET, Parks WC, . A model of primary atherosclerosis and post-angioplasty restenosis in mice. Am J Pathol. 2003;163: 773–8.
   PubMedGoogle Scholar
• Teien AN, Abildgaard U, Hook M. The anticoagulant effect of heparan sulfate and dermatan sulfate. Thromb Res. 1976;8: 859–67.
   PubMed Web of Science ®Google Scholar
• Coughlin SR. Protease-activated receptors in the cardiovascular system. Cold Spring Harb Symp Quant Biol. 2002;67: 197–208.
   PubMedGoogle Scholar
• Farb A, Sangiorgi G, Carter AJ, Walley VM, Edwards WD, Schwartz RS, . Pathology of acute and chronic coronary stenting in humans. Circulation. 1999;99:44–52.
   PubMed Web of Science ®Google Scholar
• He L, Giri TK, Vicente CP, Tollefsen DM. Vascular dermatan sulfate regulates the antithrombotic activity of heparin cofactor II. Blood. 2008;111:4118–25.
   PubMedGoogle Scholar
• Hasenstab D, Lea H, Hart CE, Lok S, Clowes AW. Tissue factor overexpression in rat arterial neointima models thrombosis and progression of advanced atherosclerosis. Circulation. 2000;101:2651–7.
   PubMedGoogle Scholar
• Kumar A, Hoover JL, Simmons CA, Lindner V, Shebuski RJ. Remodeling and neointimal formation in the carotid artery of normal and P-selectin-deficient mice. Circulation. 1997;96: 4333–42.
   PubMed Web of Science ®Google Scholar
• Li G, Sanders JM, Phan ET, Ley K, Sarembock IJ. Arterial macrophages and regenerating endothelial cells express P-selectin in atherosclerosis-prone apolipoprotein E-deficient mice. Am J Pathol. 2005;167:1511–8.
   PubMedGoogle Scholar